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1. Background and history of the Monitoring Project 
 
At the end of the 1990‟s twelve drug helplines participated in the evaluation project of FESAT. The 
results were published in the report “Evaluation on Drug Telephone Helplines. A Transnational 
European Project.”  
 
In the years that followed, the experiences from this project were used in the planning of a new 
data collection system for drug helplines in FESAT. Also, the motives of the reporting system 
shifted from evaluation to monitoring. The main goal was to identify new drugs and new drug 
trends as early as possible. Another goal was to give drug helplines a possibility to compare the 
latest trends registered by their own helpline with trends in other parts of Europe i.e. to see the 
work of their own helpline in a European context. 
 
This shift in goals was inspired by the fact that drug helplines are at the interface between people 
concerned with or confronted by drugs and services for prevention, treatment and care. Very often 
they are fulfilling the role of frontline services and are the first point of contact. Drug helplines 
across Europe have contact with tens of thousands of callers and deal with a very diverse and 
complex range of questions related to drugs. All these contacts can provide potentially relevant 
information. 
 
In practice, the idea of a bi-annual data collection is the same idea that has been used by the 
Swedish Council for Information on Alcohol and Other Drugs (CAN) in Sweden.  
 
A pilot study based on this methodology was done at the beginning of 2001. Twenty-two drug 
helplines in fifteen countries from all over Europe participated. The experiences of the pilot study 
were mainly positive. A large majority of the FESAT helplines participated and the few comments 
were positive.  
With this background, it was decided at the FESAT Board meeting in June 2001 to continue the 
Monitoring project on a regular basis. The first regular data collection covered the first six months 
of 2001. It is also worth mentioning that when the Monitoring project started, it following 
consultation with the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in 
Lisbon, a collaboration that has continued on a regular basis. 
 
After each data collection a simple but informative report is produced and distributed to the 
members of FESAT, the EMCDDA, REITOX Focal Points and other interested bodies. The reports 
are also made available for download on the FESAT website (www.fesat.org). 
 
Up until the fifteenth data collection and report, the Monitoring was dealt with by Björn Hibell. He 
was responsible from the first data collection in 2001 and continued to do so until 2007 when he 
retired from the Board of FESAT. In 2007, this task was taken over by Tom Evenepoel, FESAT 
Vice President.  
  
Since Spring 2009 the data collection has been made possible online. Thanks to the FESAT-
website all participating members are now in the possibility of filling in the questionnaire online, via 














Bi-annual data collection 
 
The idea of the FESAT Monitoring system is to collect data twice a year, using a simple 
questionnaire about changes that have been noted in the previous six months, when compared 
with the six months before that.   
 
As mentioned earlier the data collection was inspired by a similar monitoring in Sweden, where 
data were collected twice a year from about 200 reporters in about 25 municipalities all over the 
country. The study is of a rapid assessment nature, with the intention to identify trends but not to 
quantify the size of a change. 
Likewise, the FESAT monitoring collects data twice a year, using a simple questionnaire about 
changes occurring during the first six months of the year and the last six months.  
 
 
A qualitative questionnaire 
 
The data collection has a qualitative nature, which means that the intention is to identify trends but 
not to quantify the size of a change. The helplines are asked to fill in any changes for the calls they 
answered during a six months period compared to the previous six months (eg. Did they notice an 
increase in questions on cannabis?) Two of the questions in the questionnaire include several sub-
questions. However, once the idea of these questions is clear, it will not take the respondent a long 




FESAT has a wide variety of helplines amongst its members. Some countries have one helpline 
and others have several, some of which are regional. Some helpline belong to governmental 
bodies and operate nationwide, others are small non-governmental organisations. Some are 
staffed by professionals, other rely on volunteers. Since helplines are very different in size, 
geographical coverage and experience, it is sometimes doubtful in the report to mention that, for 
example, a new drug has been reported from a helpline in a named country when in fact this is 
reported from one helpline only. Because of that reason, the report will not include references to a 
certain country, but specify the helpline that has reported the data.  
 
The size of the helplines varies a lot. This of course has to be kept in mind when looking into the 
data of this report. It is one of the reasons why details on the size of each participating helplines 
are included in each report. 
 
It is important to stress that one certainly cannot expect to get a clear picture about changes in the 
use of different drugs via data from drug helplines only. That is why it is important to see the 




Changes in the questionnaire 
 
At that time, the questionnaire in the pilot study seemed to function quite well. However, 
discussions with EMCDDA and within FESAT resulted in some additional questions in the 




The reliability of the answers from a helpline may vary depending on whether the respondent 
answers the questionnaire alone or talks to colleagues. Another factor that might influence the 
possibility to give reliable information is whether the respondent has access to some kind of 
statistics produced by the helpline. To clarify this validity aspect a question has been added 
whether the respondent answered the questionnaire all by her-/himself or consulted colleagues 
and/or helpline statistics. 
 
From the first data collection covering 2005 the alternative “Not applicable” was added in the 
question on different drugs. Starting from the data collection covering the first half of 2006 a sub 
question on the number of contacts was added. In addition to asking about the number of 
telephone and e-mail enquires we also ask about the number of individual/private chats. 
 
Since the data collection covering 2006, each questionnaire for the last half of a year was 
extended with a question on the total number of calls, e-mails and chat sessions on a yearly basis.  
 
On occasion, some tailored questions were added. For example: in view of the FESAT conference 
which was held in Lisbon in October 2007 and which focussed on cannabis, a couple of extra 
questions related to cannabis were inserted. The answers to these extra questions were the basis 
for a plenary presentation at that conference. 
 
 




This report present the result of FESAT‟s 17th data collection and covers the last six months of 
2008. The respondents were asked to report about changes during this period compared to the 
previous six months period (i.e. January 1 – June 30, 2008). 
 
The questionnaire was distributed in June 2009 to all FESAT helplines (please note that not all 
FESAT members operate helplines). It was sent to the contact persons reported to FESAT or, 
when appropriate, to the person who answered the questionnaire in the previous data collection. 




The FESAT House rules state that membership for FESAT is open to telephone helplines and 
services using other communication technologies to provide help and information on drugs, alcohol 
and tobacco. Membership is also open to other organisations in the drug field (and drug related 
helplines) and to networks. Consequently not all of the approximately 40 services linked to FESAT 
at the time of the data collection operate a helpline. 
Furthermore helplines located outside of Europe (eg. two Australian members of FESAT) are not 
required to participate in the data Monitoring because of the limited relevance of data comparison. 
 
Regrettably not all helplines respond to the questionnaire. During the years that the FESAT 
Monitoring has been running, there is an overall decline in the number of participants. This 
evolution is probably due to the fact that since 2004 FESAT has experienced funding difficulties, 
which affect the resources and time that can be devoted to this task. The downscaling of FESAT‟s 
activities has inevitably led to lower involvement of the members.  
Furthermore the follow-up of the data collection is no longer done by professional staff. It involves 
the distribution and gathering of the questionnaires, a task that in the past was done by FESAT‟s 
former Project Administrator, Mariana Musat, Since then Tom Evenepoel took over these tasks on 
a voluntary basis..  




4. Methodological Considerations 
 
The intention of the data Monitoring is to identify changes and trends but not to quantify the size of 
a change. The questionnaire (of which an example is added in annex) also contains some 
questions of a qualitative nature. Two of the major questions include information about possible 
changes about the type of persons contacting the helplines and about the kinds of questions 
asked. 
 
The helplines are asked to report whether there was a “large increase”, “some increase”, “no 
change”, “some decrease” or a “large decrease” during the last six months.  
For pragmatic reasons these concepts are not objectively defined. Hence, one cannot avoid that 
the respondents have interpreted these concepts differently, which calls for caution in the 
interpretation of the data. However this approach was chosen due to the fact that not all 
participating helplines record data in the same way or in the same detail. 
 
Because of the qualitative nature of the questionnaire and the fact that not all participants base 
themselves on their helplines statistics, one might assume that the respondants are inclined to 
report more increases than decreases on the questions about who is calling and what the reasons 
are for calling. Yet, in reality this is proven not to be the case. Even thought it seems reasonable to 
assume that it is “easier” to notice an increase than a decrease and that people would take longer 
to notice a decrease, the results in previous monitoring reports show that contrary is often true. 
This means that the risk of over reporting increases and underreporting decreases rather limited.  
 
Size or weight of drug helplines 
 
Some helplines are relatively small, with few contacts a day, while others deal with a large number 
of daily enquiries. The size of the helplines, measured by the number of phone calls and online 
contacts, varies a lot. The smallest helpline answers less than 1 call per day and the largest 
helpline answers up to 100 calls. 
 
In the presentation of the results there is no distinction made between answers from small and 
large helplines. The same is also true for regional and national helplines, a fact which also calls for 
some caution in the interpretation of the results. However, when showing the answers to open-
ended questions the name of the helpline is given. This will allow the reader to better assess the 
background and source of that information. Information about the number of calls as well as about 
the number of email and chat contacts per day of each participating helpline are described in detail 
in the results further on. 
 
Finally, it should be stressed that the data in this report say nothing about the size of a possible 
change or about the magnitude of the number of calls about a specific subject. This might for 
example means that a “no change” relates to one hundred calls about a subject in a large helpline, 
while a “large increase” might mean an increase from 0 to 5 calls at a small helpline. 
 
Impact of external factors on number of calls 
 
Another aspect is how to interpret a “true” increased number of calls about a specific subject. Does 
this indicate something more than an increased number of contacts, for example an increased 
number of people using that specific drug? In many cases the answer to this is probably “no”. A 
more probable explanation is that media have reported more than usual about drugs in general or 
maybe about a specific drug. Another reason might be that national, regional or local authorities 
have run a campaign about drugs or a specific drug or about a helpline. 
 
Changes within a helpline can of course also influence the number of calls. If the number of people 
working at a helpline increases, or the opening hours increase, the result will most probably be an 
increased number of calls (and the other way around if there is a reduction in staff or opening 
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hours). Yet another aspect to consider is whether an increased number of calls about a specific 
drug to a large extent is a part of a general pattern of more people contacting the helpline. 
 
However, aspects related to possible changes in the number of calls to a helpline are partly 
“controlled for” since the questionnaire includes information about the number of calls, emails and 
chats. Of course, the scope of a reported increase (or decrease) has to be measured or compared 
to the number of calls individual helplines get.  
 
To get a better understanding of important changes in the types of persons contacting the helpline, 
or in the content of the questions, the respondents have been asked to give comments or 





In all kinds of surveys, one of the main methodological key issues is the validity, i.e. whether the 
answers reflect the true situation at the helplines. The risk of misjudgements is probably larger if 
the person answering the FESAT questionnaire does this all by themselves rather than if the 
answers are given after discussions with colleagues or after consulting possible statistics produced 
at the helpline. 
 
Table 1 below shows that slightly more than half of the respondents consulted their drug helpline‟s 
statistics (6 out of 12 respondents). Two respondents consulted colleagues at the helpline. Two of 
the respondents did both consult statistics and colleagues. Three persons filled in the 
questionnaire by themselves.  
 
 
Table 1. Possible consulting when answering the questionnaire 
(More than one answer was allowed) 
 
 
What or who did you consult? Number   
Did it all by myself 3  
Talked to colleagues at the helpline 4 
out of which 2 did both 
Consulted drug helpline statistics 6 





All the different methodological aspects which were discussed above stress the importance 
of carefulness when interpreting the data. This emphasises the comment that results from 
the FESAT Monitoring system mainly should be seen as a complement to other kinds of 




5. Results and Analyses 
 
 
5.1. Information on the participating helplines 
 
In total 12 drug helplines returned the questionnaire. They are located in the following countries (in 
alpabetic order): Belgium (2), Cyprus (1), Finland (1), Germany (1), Greece (1), Ireland (1), Latvia 
(1), the Netherlands (2), Norway (1) and Portugal (1)  i.e. all together 10 countries. 
 
Various data collections in the past lead to differences as to which helplines responded. On this 




As mentioned on several occasions earlier in this report, FESAT is a network of very diverse drug 
helplines. The wide range of differences in size and scope of these helplines is reflected in the 
numbers of calls they answer. 
 
Figure A below shows that 4 helplines (out of 11 participating services) get 10 calls or less per day, 
5 helplines answer 11 to 30 calls, 1 helplines 31-60 calls and 1 helpline deals with 61 or more calls 
per day. The two smallest each get about 1 call a day and the largest answer 45 and 15 calls per 
day. The median is 12 daily calls, which is comparable to the median in the previous data 
collection (11). 
 















Online contacts: e-mail and chat 
 
In the past years several helplines broadened their service to the public by offering counselling via 
e-mail or online chat sessions. Several helplines notice a decline in number of calls, which is 
sometimes compensated by the increase of number of online enquiries.  
 
The extent to which drug helplines have embraced online communication tools is illustrated by the 
fact that eight of out of the eleven helplines that sent in the questionnaire provide counselling via e-
mail. There are however large differences in the amount of e-mails they answer. The lowest 
numbers are „less than one‟ or one e-mail per day, the largest numbers of e-mails are 5.7 per day 
and 15 per day. The median is 3 e-mails per day. Taking into account that the median for calls is 
12, all of this is an illustration that online counselling has become an established fact in drug 
helplines across Europe.  
 
Two helplines have had experiences with online individual chat sessions (Linha Vida SOS Droga in 
Portugal and Drugs Infolijn in the Netherlands) whilst others have plans to engage in chat 
applications in the near future. The chat service of the Drugs Infolijn was part of a pilot project that 
ended in the summer of 2008. For that reason this helpline reported only 128 chat contacts. There 




5.2. The number of calls and email contacts in detail 
 
Table 2 shows the average number of calls, e- mails as well as chat contacts per day and per 
helpline.  
 
The helpline with the largest number of calls, 75 per day, is Linha Vida SOS Droga in Portugal. 
Next in size is Drogennotdienst Berlin in Germany which answered 45 calls per day. 
 
Out of all 11 helplines that answered the question, 9 services reported to get an average of less 
than 20 calls per day. Two services mentioned 5 or less daily calls, which is once more an 
illustration of the large differences between the participating helplines. 
 
As mentioned earlier, counselling via e-mail gets an increasingly important role in drug helplines.  
For example the LSOVD Helpline in the Netherlands pointed out in their reply that they noticed a 
decline in the number of telephone calls but an increase in the number of e-mails. The same kind 
of evolution has been reported earlier by De DrugLijn in Belgium. 
Still the number of e-mails answered is on average considerably lower than the number of calls. 
The Drugs Infolijn in The Netherlands reported the highest number with an average of 15 e-mails 
per day. This figure is considerably higher than in previous data collections; an increase which is 
due to the fact that early 2008 the Drugs Infolijn merged with the Alcohol Infolijn, which in itself 
answers 10 e-mailinquiries per day. Next in line is De DrugLijn in Belgium with 5.7 e-mails per 




Table 2. Number of calls, email and chat contacts per day 
 
Country Respondent calls e-mails chat  
Belgium De DrugLijn 17 5.7 - 
Belgium Infor Drogues 12 3 - 
Cyprus Perseas 1 - - 
Finland HUCH Psychiatric Unit for Drug Dependency 4   
Germany Drogennotdienst Berlin 45 3 - 
Greece OKANA SOS Drug Helpline 10 - - 
Ireland Drugs/HIV Helpline 16.3 - - 
Latvia Riga Addiction Prevention Confidential Line 12 3 - 
The Netherlands Drugs Infolijn 17 15 0.5 
The Netherlands LSOVD 1 1 - 
Norway RUStelefonen 10       -1* - 
Portugal Linha Vida SOS Droga 75 2 - 
 
* less than one 
 
 




Earlier FESAT monitoring questionnaires only collected data about the number of calls, e-mails 
and chat contacts per day. Since 2006 however, the survey for the last half of each year also 
enquires about the corresponding numbers on an annual basis. As this report regards the second 
half of 2007, the questionnaire included a question on annual data.  
 
Calls as mentioned in Table 3 are defined as a real conversation with a telephone counsellor.  
This sounds logic, but one must not forget that not all lines are open 24 hours and that not all 
callers get immediate access to the helpline. This means the number of calls out of opening hours 
(when people e.g. hear a recorded message) or “busy tones” are not included in this number. 
Another aspect that is worth mentioning is the use of so-called Voice Response Systems (VRS). 
These systems allow the caller to chose a dial and listen to pre-recorded messages. The Drugs 
Infolijn in The Netherlands is one helpline that operates such a service. In fact the number of VRS 
calls (7 000 in the year 2008) to the Drugs Infolijn outnumbers their amount of calls which a 
counsellor.  
However, calls to a VRS are not include in Table 3 either. They are of less relevance as they do 
not allow to collect the specific data about target groups and drug trends which are gathered by 
monitoring questionnaire. 
 
In 2008 there were more than 15 000 calls received by Linha Vida SOS Droga in Portugal. The 
second largest was Drugs Infolijn and Alcohol Infolijn, two helplines in the Netherlands who 
merged that merged early 2008.Together they received 4 600 calls (excluding the 7 000 VRS calls 
they received during that year).  
 
Furthermore it is worth mentioning that the Drugs/HIV Helpline from Ireland pointed out in their 
questionnaire that there was a 16% increase in calls during the 2nd half of 2008 when compared 





When looking at the number of e-mails answered, the picture is quite different.  
The largest number of received e-mails in 2007 was reported by De Druglijn in Belgium (2 231) 
and the merged Drugs Infolijn and Alcohol Infolijn in The Netherlands (2 650). The latter figure 
however does not only include e-mails, but also consultations of questions on the website of the 
Alcohol Infolijn. It has to be pointed out that in previous data collections the Riga Addiction 
Prevention Centre Confidential Line in Latvia reported a considerable amount of annual e-mails 
as well (1 775 in 2008). Unfortunately the helpline did not report any annual totals on this occasion. 
 
For most drug helplines who offer both telephone and e-mail-counselling, the number of calls is 
considerably higher than the number of e-mails. This is probably an indication of the historic fact 
that most of them simply started off as telephone helplines. It also illustrates that despite evolutions 
in online communication technology, telephone counselling is and remains their “core business‟. 
  
Online chat session 
 
In this data collection only one helpline reported offering online chat contacts. The Drugs Infolijn 
in the Netherlands ran a pilot project until the summer of 2008, after which the chat service was 
stopped due to lack of funding. During 2008 the helpline had 128 online chat sessions. 
 
Table 3. Number of calls, email and chat contacts in 2008  
 
Country Respondent (1) calls e-mail chat 
Belgium 
De DrugLijn 4 672 2 231 - 
Infor-Drogues 3 899 387 - 
Cyprus Perseas 210 - - 
Germany Drogennotdienst Berlin 3 604 130 - 
Greece OKANA SOS Drug Helpline 2 435 - - 
Ireland Drugs/HIV Helpline 3 787 - - 
The Netherlands 
Drugs Infolijn (2)  (3)  (4)  4 600 2 650 128 
LSOVD 177 47 - 
Norway RUStelefonen 3 192 341 - 
Portugal Linha Vida SOS Droga 15 860 707 16 (5) 
 
(1)  Riga Addiction Prevention Confidential Line from Latvia and HUCH Psychiatric Unit for Drug 
Dependency did not mention any annual totals in their response and are therefor not 
mentionned in this table.  
 
(2)  The amount of calls mentionned is the summ of the calls to Drugs Infolijn and Alcohol Infolijn, 
two helplines who merged that merged into one early 2008. 
 
(3)  The amount of e-mails mentionned is the summ of e-mails answered by the Drugs Infolijn and 
Alcohol Infolijn as well as internet inquiries at the website of the Alcohol Infolijn.  
 
(4)  The chat service of the Drugs Infolijn was part of a pilot project that ended in the summer of 
2008. For that reason this helpline reported only 128 chat contacts for the whole of 2008. 
 
(5) Linha Vida SOS Droga in Portugal offers online chat sessions, but not on a continuous basis, 
therefor the annual figure of sessions is low. 
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5.4. Changes in the type of persons contacting drug helplines 
 
Reported changes during the last 6 months in the type of persons contacting the helpline are 
presented in Table 4 on the next page. When interpreting these figures it is important to notice that 
some categories of callers are not applicable for some helplines. 
 
For all categories of callers the by far most frequent answer is that the number of callers was 
unchanged during the second half of 2008 compared to the situation during the first 6 months of 
that year. The only exception to that rule are the categories of “Drug using men, 26–35 years” for 
which 5 helplines reported a small increase, “Parents or guardians of drug users” for which  5 
helplines reported a some decrease and “Drug using young women, 20–25 years” for which 4 
helplines reported a some decrease  
 
For “Drug using women, 36–50 years” an equal amount of 4 helplines reported a three some 
increase and no change.  
The same pattern goes for the group of “Partners of drug users” where “no change”, “some 
increase” were each reported by 4 helplines. 
 
In total and for all categories, “no change” was scored 166 times.   
 
In the open question (question 2 in the annexed questionnaire) referring to these categories 3 
helpline added some comments concerning the groups of people contacting them. The Drugs/HIV 
Helpline from Ireland pointed out that some decreases in contacts (eg. parents/ partners/ siblings) 
are likely to be due to records not being completed fully. 
Drogennotdienst Berlin from Germany reported an increase of inquiries concerning Spice and 
especially by Media/Press, Teachers and Parents. 
The Riga Addiction Prevention Centre Confidential Line in Latvia reported in increase in the 
number of inquiries made by employers. 
 
5.4.1 Increased number of contacts  
 
In total and for all categories, “some” or “large increase” was scored 48 times.   
 
The categories of drug users for which the largest number of helplines reported increases are 
listed below: 
 
Some increase or large increase reported for: 
 Drug using men from 26-35 years: reported by 5 helplines 
 Drug using women from 36-50 years: reported by 4 helplines 
 Drug using boys from 17-19 years: reported by 4 helplines 
 Partners of drug users: reported by 4 helplines 
 
 Additionally, it is worth mentioning that each time 1 large increase was reported for the category of 























Drug using girls up to 13 years 
  
7 1 1 
 
3 
 Drug using girls, 14–16 years 
  
4 2 2 
 
4 
 Drug using girls, 17–19 years 
 
2 5 3 1 
 
1 
 Drug using young women, 20–25 years 
 
3 2 4 2 
 
1 
          Drug using women, 26–35 years 1 2 6 2 
  
1 
 Drug using women, 36–50 years 
 
4 5 1 1 
 
1 
 Drug using women, 51 years or older 
  
6 2 2 
 
2 
          Drug using boys up to 13 years 
  
4 4 1 
 
3 
 Drug using boys, 14–16 years 
  
3 3 2 
 
4 
 Drug using boys, 17–19 years 
 
4 3 3 1 
 
1 
 Drug using boys, 20–25 years 
 
3 5 1 2 
 
1 
          Drug using men, 26–35 years 
 
5 5 1 
  
1 
 Drug using men, 36–50 years 1 1 6 1 1 
 
2 
 Drug using men, 51 years or older 
 
1 7 1 1 
 
2 
          Parents or guardians of drug users 
 
1 4 5 2 
   Siblings of drug users 
 
2 8 1 1 
   Other relatives of drug users 
  
10 2 
      4       Partners of drug users 
 
4 5 2 1 
   Friends of drug users 
 
1 8 2 
  
1 







 Social workers 
 
1 8 1 
  
2 
 Doctors, nurses 
  
10 
   
2 
 Police or customs officers 1 2 7 
   
2 
          Students 
  
9 1 2 
   Teachers 
 






              Others 
 









5.4.2 Decreased number of contacts  
 
In total and for all categories, “some” or “large decrease” was scored 71 times. This number is 
higher than the number of reported increases. 
 
The categories of drug users for which the largest number of helplines reported a decrease are 
listed below. 
 
Some decrease or large decrease reported for: 
 Parents or guardians of drug users: reported by 7 helplines 
 Drug using young women from 20-25 years: reported by 6 helplines 
 Drug using boys up to 13: reported by 5 helplines 
 Drug using boys from 14-16 years: reported by 5 helplines 
 Drug using girls from 14-16 years: reported by 4 helplines 
 Drug using girls from 17-19 years: reported by 4 helplines 
 Drug using boys from 17-19 years: reported by 4 helplines 
 
It is striking to see that the category “drug using boys from 17-19 years” occurs both in the list of 
most recorded increases as well as in the above list of decreases.  
In fact, when this category is looked at in more detail, one sees that “some increase” for this 
category was reported 4 times but more, whereas “some decrease” was reported three times and a 
“large decrease” once. 
 
Two categories in Table 4 only got scores of increases or decreases. This is the case for “police 
and customs officers” for which only increases were reported and for “students”, a category for 




5.5. Changes in the questions and drugs and aspects of drug use 
 
As drug helplines deal with a wide variety of people contacting them, it is no surprise that they also 
get a broad variety of questions on a whole range of drugs and aspects related drug drugs use. 
This is perfectly illustrated by the extensiveness of Table 5. 
It must be pointed out that when the word “drug” is used, this relates not only to illicit drugs, but to 
all types of psycho-active substances. The drugs that are mentioned in italic in Table 5 are drugs 
that are not listed on the questionnaire. These were added or filled in by the respondents in order 
to specify within a category of drugs. 
 
When looking at the data, it is also important to know that not all drug helplines differentiate 
between marihuana and hashish or between cocaine and crack in their own statistics. Others do 
not differentiate between different ways of using drugs in their helpline‟s statistics. This explains 
why “not applicable” is scored relatively high for some drugs or types of drug consumption. 
 
Just like for the categories of people contacting drug helplines, the most frequent answer in Table 
5 is that the number of questions on drugs and drugs aspects was unchanged. The answer “no 
change” was scored 159 times. 
 
The biggest number of helplines that reported an increase is to be found in the question on 
alcohol as well as cocaine: 6 respondents noticed an increase for each of these drugs.  
This is a somewhat different picture from previous FESAT monitoring report, where the highest 
numbers of increases reported were related to amphetamine.  
Moreover, the fact that alcohol is in increasingly mentioned substance at drug helplines (which the 
public might perceive as services meant for illicit drug problems) is not without importance. 
 
The third most mentioned drug when it comes to increases is GHB: 5 helplines reported an 
increase. One of those was a “large increase”. The rise of questions on GHB seems to be of 
specific concern to the Dutch helplines (LSOVD and Drugs Infolijn) as both underlined this 
increase in additional notes to the questionnaire. They more specifically pointed out that they also 
noticed an increase in questions on GBL, a precursor to GHB. 
 
For the drug Ecstasy, just like for “magic mushrooms” there is an equal amount of reported 
increases and decreases. For hashish and marihuana a slightly higher number of increases than 
decreases was reported. 
  
Another remarkable fact is that several drug helplines notice a decrease in the number of 
questions on heroin (mainly injected but also on smoking heroin). This is in line with the decrease 
in questions on heroin mentioned in the previous FESAT monitoring. In fact a decrease has been 
reported by several helplines for sixth reports in a row. 
 
Last but not least, a larger number of decreases and only one increase in questions on 
amphetamines was reported. This is remarkable as amphetamine was the drug for which the 
highest number of increases was reported in the previous (16th) data collection. 
 
  
5.5.1 Increased number of contacts on drugs 
 
In total and for all categories, “some” or “large increase” was scored 52 times. As will be illustrated 
further on, this number is in perfect balance with the number of reported decreases.  







Some increase or large increase reported for: 
 Alcohol and cocaine: reported by 6 helplines 
 GHB: reported by 5 helplines 
 Ecstasy and marihuana: reported by 3 helplines 
 
The three reports of an increase on Ecstasy should be put in perspective with an equal amount of 
decreases (one of was a “large increase”).  
 
 
5.5.2 Decreased number of contacts  
 
In total and for all categories, “some” or “large decrease” was scored 52 times. As mentioned this 
is exactly the same amount as the number of reported increases.  
 
The drugs or categories of drugs for which the largest number of helplines reported an decrease in 
contacts are: 
 
Some decrease or large decrease reported for: 
 Heroin injecting: reported by 4 helplines 
 Ecstasy, benzodiazepines and „other medication‟: reported by 3 helplines 
 
The reported decreases in questions on heroin where discussed earlier in this report. For Ecstasy 
it was already pointed out that the reports for these drugs are ambivalent: an equal amount of drug 
helplines reported an increase and a decrease. 
 
Just like in the previous data collection, one helpline reported a „large decrease‟ in questions on 
benzodiazepines. Once more it was OKANA SOS Drug Helpline from Greece who reported this. 
In fact, this helpline also that reported a „large decrease‟ for the category „other medication‟.  
 
 
5.5.3 Specific mentions 
 
The drugs that are mentioned in italic in Table 5 are drugs that are not listed on the questionnaire 
sent out to the respondents. Each drug mentioned in italic in the table was added or filled in by the 
respondents in order to specify within a category of drugs. 
 
In the category ‘other opiates’  
 
De DrugLijn from Belgium marked „some increase‟ in the number of questions on 
methadone. OKANA SOS Drug Helpline from Greece mentioned an increase regarding 
Subutex and subutone. In a comment they added noticing an „increase of questions 
concerning substitutes and ways of using them‟. 
On the other hand, the Riga Addiction Prevention Centre Confidential Line in Latvia 






In the category ‘other synthetic drugs’  
 
The Riga Addiction Prevention Centre Confidential Line in Latvia reported some 
decrease in the number of calls about DMT, PCP and BZP.  
Furthermore it should be noted that methamphetamine which was mentioned in the 
previous data collection was no longer reported by any of the participants on this occasion. 
 
In the category ‘inhalents’  
 
De DrugLijn from Belgium reported a „large decrease‟ in both the number of questions on 
poppers and solvents (gasses). 
 
In the category ‘other drugs’  
 
„De DrugLijn from Belgium mentioned that they did not notice any significant change in the 
number of inquiries about Ketamine. 
 
Spice‟, a drug contain synthetic cannabinoids, which was reported in previous FESAT 
Monitoring reports, was mentioned by two helplines. However, one of them reported „some 
increase‟, whilst the other mentioned a „large decrease'. Drogennotruf Berlin from 
Germany added following feedback: „Some increase in counselling / information on spice, 
especially by media/press, Teachers and parents, but not by the users themselves. The 
large decrease was reported by the Riga Addiction Prevention Centre Confidential Line 
in Latvia 
 
The Drugs Infolijn from the Netherlands mentioned a „small increase‟ in number of  
questions related to GBL, which is of course linked to the increase in number of questions 
on GHB, as GBL is the precursor for this drug. However, the Drugs Infolijn added that this 
increases was ‟partly due to an increase in media coverage‟. 
 
Furthermore, the Riga Addiction Prevention Centre Confidential Line from Latvia 
reported a large decrease in the question about Efedrine and some decrease in the 




5.5.4 Changes in contacts on aspects of drug use  
 
Regarding the contacts on prevention, medical aspects, legislation and relationship problems, most 
helplines once more report a majority of „no change‟. 
 
However, two drug helplines report a small increase in the question on legal aspects. The history 
of the FESAT monitoring shows that such changes in the number of questions on legal issues are 
often linked to changes in national legislation in specific countries. As drug legislation as well as 
tobacco and alcohol legislation have proven to be all but static in several European countries, this 
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Annex: Example of the questionnaire 
 
FESAT Monitoring System. Fall 2008 
Name:       
Drug helpline:       
Date:       
 
1. Compared to the situation in the first half of 2008 (January-June) the type of persons contacting the 
helpline in the second half of 2008 (July-December) have changed in the following way: 
 Large Some No Some Large Don’t Not 
 increase increase change decrease decrease know applicable 
Drug using girls up to 13 years        
Drug using girls, 14–16 years        
Drug using girls, 17–19 years        
Drug using girls, 20–25 years        
 
Drug using women, 26–35 years        
Drug using women, 36–50 years        
Drug using women, 51 years or older        
 
Drug using boys up to 13 years        
Drug using boys, 14–16 years        
Drug using boys, 17–19 years        
Drug using boys, 20–25 years        
 
Drug using men, 26–35 years        
Drug using men, 36–50 years        
Drug using men, 51 years or older        
 
Parents or guardians of drug users        
Siblings of drug users        
Other relatives of drug users        
Partners of drug users        
Friends of drug users        
Work colleagues/drugs professionals        
Social workers        
Doctors, nurses        
Police or customs officers        
 
Students        
Teachers        
Media/press        
 
Others:              
 19 
 
2. Any important changes about the contacts that you want to stress? 
 (For example explaining/commenting important increases or decreases or new categories that 
 have begun to contact the helpline) 
 
  No 
 
 Yes Please describe and interpret: 
      
 
 
  Please describe and interpret: 
      
 
 
  Please describe and interpret: 





3. Do you have any comments about the number of contacts from people asking for information 
BEFORE they use a drug (’potential use’) rather than asking for help because they have a problem 
regarding drugs that they have ALREADY used? 
 
  No 
 
  Yes Please describe and interpret: 
      
 
  Please describe and interpret: 
      
 20 
 
4.  Compared to the situation in the first half of 2008 (January-June), the number of questions (which can 
be telephone calls, e-mails or chat sessions) during the second half of 2008 (July-December) about different 
drugs and aspects have changed in the following way: 
 
 Large Some No Some Large Don’t Not 
 increase increase change decrease decrease know applicable 
Number of contacts about hashish        
Number of contacts about marihuana        
Number of contacts on injecting heroin        
Number of contacts about the smoking 
    of heroin        
Number of contacts about other opiates, 
    such as              
                              
 
Number of contacts about cocaine        
Number of contacts about crack        
Number of contacts about LSD        
Number of contacts about ”magic 
    mushrooms”        
 
Number of contacts about injecting 
    amphetamines        
Number of contacts about using  
    amphetamines in other ways        
Number of contacts about Ecstasy        
Number of contacts about other synthetic 
    drugs, such as (fill in)        
                                        
 
Number of contacts about khat        
Number of contacts about GHB        
Number of contacts on benzodiazepines        
Number of contacts on other medications        
Number of contacts about inhalants, 
    such as (fill in)        
                              
 
Number of contacts about anabolic steroids 
    or other doping agents        
Number of contacts about alcohol        
Number of contacts about tobacco        
 
Number of contacts about other drugs, 
    such as (fill in)        
                              
 
Number of contacts about prevention        
Number of contacts about legal aspects        
Number of contacts on medical aspects        




5. Any important changes about the number of questions about different drugs that you want to 
stress? 
For example explaining/commenting increases or decreases in the number of questions about some specific 
drugs (question 4)or comments about changes in the relationship between calls and callers (question 1) 
 
  No 
 
  Yes Please describe and interpret: 
      
 
  Please describe and interpret: 
      
 
6. Any important changes in the pattern of drug use during the second half of 2007 (July-December)? 
 
  No 
 
  Yes Please describe and interpret: 
      
 
  Please describe and interpret: 
      
 
7.  About how many telephone and e-mail enquiries or individual chat contacts during the second half 
of 2007 (July-December) do your answers relate to? 
 
 About       telephone calls a day 
 
 About       e-mail enquiries a day 
 




7 b. Additional question: How many contacts did your helpline have in the whole of  the year 2008?  
 
….  telephone calls with a counsellor in 2008 
 
….  telephone calls to recorded messages in 2008 (if applicable) 
 
…..  telephone calls outside of the helpline’s opening hours in 2008 (if applicable) 
 
….   e-mail enquiries in the whole of 2008 (if applicable) 
 
….  individual/private chat sessions in the whole of 2008 (if applicable) 
 
 
8. Are there any important differences between the nature of the telephone enquiries and e-mail 
enquiries or chat sessions? 
 
  No 
 
  Yes Please describe and interpret: 
      
 
9. Did you get questions during the second half of 2007 (July-December) about any new type of drug, 
which you have not reported before or about old drugs that are used in a new way? 
 
  No 
  Yes, about the following drug(s): 
 
Type of drug / name / street name:       
Appearance:       
Route of administration:       
Quantities consumed:       
Who uses it:       
Known symptoms:       
Perceived health risks:       





Type of drug / name / street name:       
Appearance:       
Route of administration:       
Quantities consumed:       
Who uses it:       
Known symptoms:       
Perceived health risks:       
Perceived social risks:       
 
 
10. Did you answer the questionnaire all by yourself or did you talk to colleagues at the help line 
 and/or consult statistics produced by your helpline? (Mark all that apply) 
 
 I did it all by myself I talked to colleagues I consulted drug I consulted  
  at the help line help line statistics other source(s) 
  
     
 
If you consulted other sources, please specify in the box below 
 




11. Any other information you want to give? 
  (E.g. example changes in your service that might have influenced changes reported above) 
 









FESAT is a network of Drug Helplines services across Europe and beyond who aim to promote co-
operation and exchange between its members, with the ultimate aim of improving the quality of 
drug helplines services being offered to its service users. The network holds a charter of ethical 
principles to which all members much adhere.  
FESAT was officialy founded as an NGO in 1993. Since that date and with the support of the 
European Commission, it managed to run several projects. 
 
FESAT work includes:  
 FESAT Monitoring- statistical reports monitoring trends in drug use across member 
organisations.  
 Conferences  
 Learning Exchange visits between Drug Helplines in Europe 
 Training seminars on relevant topics 
 Publications such as Families and Drug Helplines; Guidelines for Good Practice on 
telephone helplines (German) ; Guidelines for setting up a helpline; Equal Access for all 
Ethnic Minorities and Drug Helplines; and Drug Helplines and Legal Aspects.  
 A series of magazines in French and English entitled Lines 
 Regular e-newsletters from 2005 to date 
 
 
FESAT, c/o VAD, Vanderlindenstraat 15, B-1030 Brussels    
email: info@fesat.org     
web:  www.fesat.org 
 
 
 
 
 
